Tissue fatty acids

Tissue fatty acids refer to the collective composition of various fatty acid species—including saturated, monounsaturated, and polyunsaturated varieties—found within biological tissues such as adipose, liver, and muscle [4, 7]. They serve as essential building blocks for cellular membranes, primary substrates for energy production through beta-oxidation, and critical signaling mediators that influence gene expression [13, 16]. The specific profile of these fatty acids is often used as a long-term biomarker of dietary intake and metabolic status, as tissue levels (particularly in adipose tissue or red blood cell membranes) reflect fatty acid consumption over months or years [1, 2, 5]. Imbalances in tissue fatty acid composition, such as an elevated omega-6 to omega-3 ratio or high saturated fat content, are significantly associated with chronic inflammatory and metabolic diseases [10, 11]. These include cardiovascular disorders, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD), where lipid accumulation can lead to cellular dysfunction and lipotoxicity [8, 17, 18]. While "tissue fatty acids" is a categorical term for metabolites rather than a specific protein target, pharmacological strategies—such as omega-3 supplementation or the use of fibrates—aim to modify these tissue profiles to reduce inflammation and improve insulin sensitivity by modulating the activity of fatty acid sensors like PPARs [8, 16, 20].

Other names

Adipose tissue fatty acidsCellular fatty acidsFree fatty acids (FFA)Non-esterified fatty acids (NEFA)Membrane fatty acidsTissue lipid profileIntracellular fatty acids

Modulation of cellular membrane fluidity and structure [7, 19]; activation of nuclear receptors such as Peroxisome Proliferator-Activated Receptors (PPARs) and G protein-coupled receptors (FFARs) [14, 16]; competition with arachidonic acid to reduce the production of pro-inflammatory eicosanoids [10, 20]; and regulation of lipogenic or oxidative gene expression [4, 16].